Company profile
Innovation is the driving force for Ruibang to carry forward its past achievements and usher in the future. The original intention behind the birth of every product is to originate from clinical practice. Based on the concepts of innovation and clinical proximity, in 2019, the companys R&D investment accounted for 17.13％ of its current operating income. Since its listing in 2011, the cumulative investment has exceeded 1.255 billion yuan. It has formed close cooperative relationships with nearly 30,000 medical institutions and provides high-quality products and solutions to most of the top-tier hospitals across the country. Create an outstanding global brand and make customers proud to own Ribangs products. Since expanding its overseas market in 2000, Ruibang has been dedicated to providing value-driven, innovative and high-quality international medical products and services for 20 years. It has been committed to building a solid and comprehensive global sales network, improving the health conditions of people in over 170 countries around the world, and continuously creating quality products to benefit everyone with the fruits of medical innovation.
Address:
公司网址
